These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 11861664)

  • 41. Effect of L-carnitine treatment on very low density lipoprotein kinetics in the hyperlipidemic rabbit.
    James L; Bhuiyan AK; Foster D; Seccombe D
    Clin Biochem; 1995 Aug; 28(4):451-8. PubMed ID: 8521601
    [TBL] [Abstract][Full Text] [Related]  

  • 42. VLDL-triglyceride production after alcohol ingestion, studied using [2-13C1] glycerol.
    Siler SQ; Neese RA; Parks EJ; Hellerstein MK
    J Lipid Res; 1998 Dec; 39(12):2319-28. PubMed ID: 9831620
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Ten weeks of aerobic training does not result in persistent changes in VLDL triglyceride turnover or oxidation in healthy men.
    Nellemann B; Christensen B; Vissing K; Thams L; Sieljacks P; Larsen MS; Jørgensen JO; Nielsen S
    Eur J Endocrinol; 2014 Nov; 171(5):603-13. PubMed ID: 25117466
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Endogenous triglyceride turnover in liver and plasma of the dog.
    Gross RC; Eigenbrodt EH; Farquhar JW
    J Lipid Res; 1967 Mar; 8(2):114-25. PubMed ID: 14564717
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Contribution of de novo fatty acid synthesis to very low density lipoprotein triacylglycerols: evidence from mass isotopomer distribution analysis of fatty acids synthesized from [2H6]ethanol.
    Yang LY; Kuksis A; Myher JJ; Steiner G
    J Lipid Res; 1996 Feb; 37(2):262-74. PubMed ID: 9026525
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Catabolic defect of triglyceride is associated with abnormal very-low-density lipoprotein in experimental nephrosis.
    Furukawa S; Hirano T; Mamo JC; Nagano S; Takahashi T
    Metabolism; 1990 Jan; 39(1):101-7. PubMed ID: 2294370
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effects of CETP inhibition with anacetrapib on metabolism of VLDL-TG and plasma apolipoproteins C-II, C-III, and E.
    Millar JS; Lassman ME; Thomas T; Ramakrishnan R; Jumes P; Dunbar RL; deGoma EM; Baer AL; Karmally W; Donovan DS; Rafeek H; Wagner JA; Holleran S; Obunike J; Liu Y; Aoujil S; Standiford T; Gutstein DE; Ginsberg HN; Rader DJ; Reyes-Soffer G
    J Lipid Res; 2017 Jun; 58(6):1214-1220. PubMed ID: 28314859
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Lactate increases hepatic secretion of VLDL-triglycerides in humans.
    Sondermeijer BM; Battjes S; van Dijk TH; Ackermans MT; Serlie MJ; Nieuwdorp M; Groen AK; Dallinga-Thie GM; Stroes ES
    Atherosclerosis; 2013 Jun; 228(2):443-50. PubMed ID: 23540683
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effects of exercise on VLDL-triglyceride oxidation and turnover.
    Sondergaard E; Rahbek I; Sørensen LP; Christiansen JS; Gormsen LC; Jensen MD; Nielsen S
    Am J Physiol Endocrinol Metab; 2011 May; 300(5):E939-44. PubMed ID: 21386064
    [TBL] [Abstract][Full Text] [Related]  

  • 50. ApoAV reduces plasma triglycerides by inhibiting very low density lipoprotein-triglyceride (VLDL-TG) production and stimulating lipoprotein lipase-mediated VLDL-TG hydrolysis.
    Schaap FG; Rensen PC; Voshol PJ; Vrins C; van der Vliet HN; Chamuleau RA; Havekes LM; Groen AK; van Dijk KW
    J Biol Chem; 2004 Jul; 279(27):27941-7. PubMed ID: 15090553
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Impaired Insulin Suppression of VLDL-Triglyceride Kinetics in Nonalcoholic Fatty Liver Disease.
    Poulsen MK; Nellemann B; Stødkilde-Jørgensen H; Pedersen SB; Grønbæk H; Nielsen S
    J Clin Endocrinol Metab; 2016 Apr; 101(4):1637-46. PubMed ID: 26829441
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Plasma adiponectin concentration is strongly associated with VLDL-TG catabolism in postmenopausal women.
    Lapointe A; Tchernof A; Lamarche B; Piché ME; Weisnagel J; Bergeron J; Lemieux S
    Nutr Metab Cardiovasc Dis; 2011 Apr; 21(4):254-60. PubMed ID: 20153614
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Atorvastatin plus omega-3 fatty acid ethyl ester decreases very-low-density lipoprotein triglyceride production in insulin resistant obese men.
    Ng TW; Ooi EM; Watts GF; Chan DC; Barrett PH
    Diabetes Obes Metab; 2014 Jun; 16(6):519-26. PubMed ID: 24299019
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Reduced very-low-density lipoprotein fractional catabolic rate in apolipoprotein C1-deficient mice.
    Jong MC; van Ree JH; Dahlmans VE; Frants RR; Hofker MH; Havekes LM
    Biochem J; 1997 Jan; 321 ( Pt 2)(Pt 2):445-50. PubMed ID: 9020879
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Energy expenditure, insulin, and VLDL-triglyceride production in humans.
    Gormsen LC; Jensen MD; Schmitz O; Møller N; Christiansen JS; Nielsen S
    J Lipid Res; 2006 Oct; 47(10):2325-32. PubMed ID: 16849776
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Increased hepatic secretion of very-low-density-lipoprotein apolipoprotein B-100 in heterozygous familial hypercholesterolaemia: a stable isotope study.
    Cummings MH; Watts GF; Umpleby M; Hennessy TR; Quiney JR; Sönksen PH
    Atherosclerosis; 1995 Feb; 113(1):79-89. PubMed ID: 7755658
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Systemic delivery of estradiol, but not testosterone or progesterone, alters very low density lipoprotein-triglyceride kinetics in postmenopausal women.
    Smith GI; Reeds DN; Okunade AL; Patterson BW; Mittendorfer B
    J Clin Endocrinol Metab; 2014 Jul; 99(7):E1306-10. PubMed ID: 24694337
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Alterations in lipid kinetics in men with HIV-dyslipidemia.
    Reeds DN; Mittendorfer B; Patterson BW; Powderly WG; Yarasheski KE; Klein S
    Am J Physiol Endocrinol Metab; 2003 Sep; 285(3):E490-7. PubMed ID: 12746213
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Portal vein and systemic adiponectin concentrations are closely linked with hepatic glucose and lipoprotein kinetics in extremely obese subjects.
    Magkos F; Fabbrini E; Patterson BW; Eagon JC; Klein S
    Metabolism; 2011 Nov; 60(11):1641-8. PubMed ID: 21632078
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Sensitivity to acute insulin-mediated suppression of plasma free fatty acids is not a determinant of fasting VLDL triglyceride secretion in healthy humans.
    Carpentier A; Patterson BW; Leung N; Lewis GF
    Diabetes; 2002 Jun; 51(6):1867-75. PubMed ID: 12031975
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.